This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Erimos Pharmaceuticals, LLC, Johns Hopkins University. Active years: 2010.
Company Filing History:
1 out of 8 
1 out of 3,794 
Years Active: 2010
Title: The Innovative Contributions of Elaine Lin
Introduction
Elaine Lin is an accomplished inventor based in New York, NY, whose work primarily focuses on innovative medical treatments. With a significant patent to her name, she has contributed to advancements in the field of tumor treatment through her groundbreaking methods and compositions.
Latest Patents
Elaine's most notable patent is titled "Methods for Delivery of Catecholic Butanes for Treatment of Tumors." This invention outlines kits, methods, and compositions that provide an effective approach for treating tumors and other proliferative diseases. The compositions include a substantially pure preparation of catecholic butanes, such as NDGA (Nordihydroguaiaretic acid) compounds, formulated with a pharmaceutically acceptable carrier. This method allows for the administration of catecholic butanes to be done through routes other than direct injection or topical application, offering new avenues for treatment.
Career Highlights
Throughout her career, Elaine has worked with notable organizations that have propelled her innovations. She has been associated with Erimos Pharmaceuticals, LLC, where her contributions have been pivotal in developing pharmaceutical solutions. Additionally, Elaine has collaborated with The Johns Hopkins University, a prestigious institution known for its research excellence.
Collaborations
Elaine's professional journey includes collaborations with esteemed colleagues such as Ru Chih C Huang and Richard Park. These partnerships have played a crucial role in her research and the successful development of her patented methods for delivering catecholic butanes.
Conclusion
Elaine Lin exemplifies the spirit of innovation in the medical field with her patent addressing a significant health challenge. Her work not only demonstrates her dedication to advancing treatment options for tumors but also highlights the impact of collaboration among talented professionals in the research community. As an inventor, Elaine continues to pave the way for future innovations in medical treatments.